KENILWORTH, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that Gregory Oakes has been appointed vice president, Corporate Accounts, U.S. Managed Markets. Most recently, Oakes was the executive director of Corporate Accounts and he will continue to be responsible for leading a team of National Account Managers charged with assuring managed care access for all core promoted products at the company’s largest national accounts and Pharmacy Benefits Managers throughout the country. In addition, he will assume responsibility for Schering-Plough’s national trade accounts. In this new role, Oakes also will be responsible for developing and implementing profitable contracting strategies for this important customer group. He is based in Kenilworth and reports to Jeffrey Berkowitz, group vice president, U.S. Managed Markets.
Oakes joined Schering-Plough in 1993 as a sales representative in western Pennsylvania and southwest New York and subsequently held a series of increasingly responsible positions within the sales organization. He has served as a district manager, regional account manager, national account manager and managed care regional director.
Oakes obtained a B.S. degree from Edinboro University in Pennsylvania and an M.B.A. from Clemson University.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough’s vision is to earn the trust of the physicians, patients and customers served by its more than 30,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.
Schering-Plough Corporation
CONTACT: Media Contact - Denise Foy, +1-908-298-7616; or Investor Contact- Alex Kelly, +1-908-298-7436
Web site: http://www.schering-plough.com/
Company News On-Call: http://www.prnewswire.com/comp/777050.html /
